DK1135154T3 - Forbedring af follikulogenese - Google Patents

Forbedring af follikulogenese

Info

Publication number
DK1135154T3
DK1135154T3 DK99961017T DK99961017T DK1135154T3 DK 1135154 T3 DK1135154 T3 DK 1135154T3 DK 99961017 T DK99961017 T DK 99961017T DK 99961017 T DK99961017 T DK 99961017T DK 1135154 T3 DK1135154 T3 DK 1135154T3
Authority
DK
Denmark
Prior art keywords
gdf
folliculogenesis
improvement
gonadotropins
maturation
Prior art date
Application number
DK99961017T
Other languages
English (en)
Inventor
Duin Marcel Van
Ursula Maria Rose
Original Assignee
Akzo Nobel Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel Nv filed Critical Akzo Nobel Nv
Application granted granted Critical
Publication of DK1135154T3 publication Critical patent/DK1135154T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06Animal cells or tissues; Human cells or tissues
    • C12N5/0602Vertebrate cells
    • C12N5/0608Germ cells
    • C12N5/0609Oocytes, oogonia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18Growth factors; Growth regulators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10Growth factors
    • C12N2501/19Growth and differentiation factors [GDF]
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00Active agents used in cell culture processes, e.g. differentation
    • C12N2501/30Hormones
    • C12N2501/31Pituitary sex hormones, e.g. follicle-stimulating hormone [FSH], luteinising hormone [LH]; Chorionic gonadotropins
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2517/00Cells related to new breeds of animals
    • C12N2517/10Conditioning of cells for in vitro fecondation or nuclear transfer

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Genetics & Genomics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cell Biology (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Diabetes (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK99961017T 1998-12-01 1999-11-25 Forbedring af follikulogenese DK1135154T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP98204048 1998-12-01
PCT/EP1999/009210 WO2000032222A1 (en) 1998-12-01 1999-11-25 Improvement of folliculogenesis

Publications (1)

Publication Number Publication Date
DK1135154T3 true DK1135154T3 (da) 2003-08-11

Family

ID=8234412

Family Applications (1)

Application Number Title Priority Date Filing Date
DK99961017T DK1135154T3 (da) 1998-12-01 1999-11-25 Forbedring af follikulogenese

Country Status (11)

Country Link
US (1) US6660717B1 (da)
EP (1) EP1135154B1 (da)
JP (1) JP2002531414A (da)
AT (1) ATE239495T1 (da)
AU (1) AU770933B2 (da)
CA (1) CA2353085A1 (da)
DE (1) DE69907725T2 (da)
DK (1) DK1135154T3 (da)
ES (1) ES2200579T3 (da)
PT (1) PT1135154E (da)
WO (1) WO2000032222A1 (da)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1176976B2 (en) * 1999-05-07 2015-10-21 Laboratoires Serono SA Use of lh administered in mid- or late-follicular phase for the treatment of anovulatory women
NZ502796A (en) * 2000-06-15 2003-02-28 Agres Ltd Nucleotide and amino acid sequences of oocyte factors related to GDF-9B or GDF-9
CA2615006A1 (en) * 2005-07-18 2007-01-25 Adelaide Research And Innovation Pty Ltd Modulation of granulosa cell apoptosis
CA2894479A1 (en) 2011-12-14 2013-06-20 The Board Of Trustees Of The Leland Stanford Junior University Stimulation of ovarian follicle development and oocyte maturation
CN112010271B (zh) * 2020-09-28 2022-03-25 江南大学 一种球形硒纳米颗粒及其制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4196123A (en) * 1978-11-20 1980-04-01 Eugenia Rosemberg Hybrid chorionic gonadotropin preparations and methods for stimulating ovulation using same
US4725579A (en) * 1985-02-21 1988-02-16 Serono Laboratories, Inc. Method of in vitro fertilization by a unique combination of gonadotropins
US5821056A (en) * 1993-01-12 1998-10-13 The Johns Hopkins University School Of Medicine Growth differentiation factor-9
CA2153653C (en) 1993-01-12 2010-12-07 Se-Jin Lee Growth differentiation factor-9
CA2181711A1 (en) 1994-01-20 1995-07-27 Renato De Leeuw New composition of glycoprotein isoforms having follicle stimulating activity
WO1997031020A1 (en) 1996-02-22 1997-08-28 The General Hospital Corporation METHODS AND COMPOSITIONS FOR ENHANCING CELLULAR RESPONSE TO TGF-β LIGANDS
DE69814352T3 (de) 1997-02-07 2009-08-13 Stryker Corp., Kalamazoo Matrixlose osteogene vorrichtungen und implantate und verfahren zu deren verwendung

Also Published As

Publication number Publication date
AU1777800A (en) 2000-06-19
CA2353085A1 (en) 2000-06-08
DE69907725T2 (de) 2004-03-18
JP2002531414A (ja) 2002-09-24
DE69907725D1 (de) 2003-06-12
ES2200579T3 (es) 2004-03-01
PT1135154E (pt) 2003-08-29
ATE239495T1 (de) 2003-05-15
US6660717B1 (en) 2003-12-09
EP1135154B1 (en) 2003-05-07
AU770933B2 (en) 2004-03-11
EP1135154A1 (en) 2001-09-26
WO2000032222A1 (en) 2000-06-08

Similar Documents

Publication Publication Date Title
GT199800197AA (es) Proceso para la sintesis de 1,3-dioles
NO993053L (no) Blanding for å farge keratinfibre og fargemetode for anvendelse derav
DE69726714T2 (de) 9-oximsilyl erythromycin a derivate
TR200602095T2 (tr) Hümanize Anti-LT-Beta-R antikorları
ATE397488T1 (de) Vorrichtung zur herstellung von liposomen
EA199700170A1 (ru) Способ получения некоторых азациклогексапетидов
ID26992A (id) Kantong berisi pengharum yang lepas lama metode penggunaannya dan metode pembuatannya
AU3327795A (en) Natriuretic cyclic compounds
KR970704430A (ko) 전립선 질환, 자궁내막증 및 비만증의 치료를 위한 드롤록시펜의 용도(use of droloxifene for the treatment of prostatic diseases endometriosis and obesity)
DK0880350T3 (da) Behandling af dissemineret sklerose
DK1032378T3 (da) Anvendelse af en blanding af en diol og en alfa-hydroxysyre til behandling af hyperkeratosiske hudsygdomme
DK1135154T3 (da) Forbedring af follikulogenese
EE200200337A (et) Uued ühendid ning nende kasutamine
PT99894A (pt) Processo para a preparacao de compostos 2-aril-5-(trifluorometil)-2-pirroles insecticidas
PL315777A1 (en) Novel analgesic and locally anaesthetising agents
DE69533311D1 (de) Verfahren zur behandlung von autoimmunerkrankungen mittels typ-1-interferonen
AU736977C (en) Peptide-based immunotherapeutic agent
MY133881A (en) "calcilytic compounds"
BR0012006A (pt) Método para evitar inflamações, doenças autoimunes e crescimento de tumor, e, uso de substâncias que suprimem a ativação mediada por ltbr
BR9510198A (pt) Composto azo pirazolona processo para a sua preparação e utilização do composto
DE69721831D1 (de) Aphrodisiakum zur anwendung an den geschlechtsorganen
ATE270113T1 (de) Zusammenstellungen zur verbesserten wundheilung
AU4193800A (en) Use of tagatose to enhance key blood factors
DK0697854T3 (da) Anvendelse af hydroxynapthalener i farvemidler.
HN1998000013A (es) Metodo para la preparacion de (is,4q)-1-azabiciclo (2.2.1) heptano 3-uno y (1r,45), 1-azabiciclo (2.2.1) heptano 3-uno.